Loading clinical trials...

TERMINATED

OLIF25™ /OLIF51™ Study

A Multi-Center, Prospective, Observational Study to Assess Outcomes for Patients Treated for Lumbar Spinal Conditions Using an OLIF25™ and/or OLIF51™Approach

NCT02657421•Medtronic Spinal and Biologics

View on ClinicalTrials.gov

Summary

The purpose of this single-arm observational study is to observe and document clinical outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc disease or degenerative scoliosis, and report the rate of adverse events of interest through the 24 months follow-up visit.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Patient is 18 years of age or older.
•2. Patient agrees to participate in the study and is able to sign the informed consent/data release form.
•3. Patient is undergoing surgery from L2-L5 for OLIF25™ and/or from L5-S1 for OLIF51™ for degenerative disc disease or degenerative scoliosis.

Exclusion Criteria

•1\. Illiterate or vulnerable patients (e.g. minors, participants incapable of judgment).

Locations (12)

Advanced Neurosurgery Associates

Murrieta, California, United States

University of California San Francisco (UCSF)

San Francisco, California, United States

The B.A.C.K. Center

Melbourne, Florida, United States

Foundation for Orthopaedic Research and Education (FORE)

Tampa, Florida, United States

NewYork-Presbyterian/The Allen Hospital

New York, New York, United States

Alleghany Health Network Research Institute

Pittsburgh, Pennsylvania, United States

Ste Elisabeth hospital

Brussels, Belgium

FN Ostrava

Ostrava, Poruba, Czechia

Clinique Du Mail

La Rochelle, France

Azienda Ospedaliera - Ospedale Civile di Legnano

Legnano, Italy

Key Dates

Start Date

November 1, 2015

Primary Completion Date

May 3, 2018

Completion Date

May 3, 2018

Last Updated

June 4, 2018

Enrollment

168

ACTUAL participants

Conditions

Degenerative Disc DiseaseScoliosis

Interventions

Oblique Lateral Interbody Fusion

PROCEDURE

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

NCT07254806

Degenerative Disc Disease

View study

RECRUITINGNA

Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis

NCT06365892

Adolescent Idiopathic Scoliosis (AIS)

View study

RECRUITINGNA

3D, Dynamic and Mechanically-informed Decision Making in AIS

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 4, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

OLIF25™ /OLIF51™ Study

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis

3D, Dynamic and Mechanically-informed Decision Making in AIS

"Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2)

MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

Personalized Prevention and Treatment Strategies for Adolescent Idiopathic Scoliosis Via a Comprehensive Health Management Platform